5-Hydroxytryptamine(1A) receptor-mediated effects on adenylate cyclase and nitric oxide synthase activities in rat ventral prostate

Cellular Signalling

Volumn 10, Issue 8, 1998, Pages 583-587

  Carmena, M J ^a   Camacho, A ^a   Solano, R M ^a   Montalvo, L ^a   Garcia Lopez E ^b   Arias, A ^b   Prieto, J C ^a  

^a U de Neuroendocrinologia Molec   (Spain)

^b UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Adenylate cyclase; NOS; Rat prostate; Serotonin receptors; VIP

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; ADENYLATE CYCLASE; DITERPENE; FORSKOLIN; NITRIC OXIDE SYNTHASE; SEROTONIN 1A RECEPTOR; SEROTONIN 1 RECEPTOR; SEROTONIN AGONIST; SEROTONIN RECEPTOR; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE VENTRAL LOBE; RAT; SIGNAL TRANSDUCTION; ANIMAL; DRUG EFFECT; IN VITRO STUDY; METABOLISM; PHYSIOLOGY; PROSTATE; WISTAR RAT;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ADENYLATE CYCLASE; ANIMALS; FORSKOLIN; MALE; NITRIC OXIDE SYNTHASE; PROSTATE; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN AGONISTS; SIGNAL TRANSDUCTION; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0031593840     PISSN: 08986568     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0898-6568(97)00196-4     Document Type: Article

References (20)

1. Vittoria A., La Mura E., Cocca T., Cecio A. J. Anat. 171:1990;169-178.
2. Abrahamson P.A., Wadström L.B., Alumets J., Falkmer S., Grimelius L. Pathol. Res. Pract. 182:1987;298-307.
3. Chapple C.R., Crowe R., Gilpin S.A., Gosling J., Burnstock G. J. Urol. 146:1991;1637-1644.
4. Weinstein M.H., Partin A.W., Veltri R.W., Epstein J.I. Hum. Pathol. 27:1996;683-687.
5. Abdul M., Logothetis C.J., Hoosein N.M. J. Urol. 154:1995;247-250.
6. 1 serotonin binding sites. In: The Serotonin Receptors (Sanders-Bush E., Ed), pp. 23-52. Humana Press, Clifton, NJ.
7. Albert P.R., Zhou Q.Y., Vantol H.H.M., Bunzow J.R., Civelli O. J. Biol. Chem. 265:1990;5825-5832.
8. Liu Y.F., Albert P.R. J. Biol. Chem. 266:1991;23689-23697.
9. Barnett N.L., Osborne N.N. Exp. Eye Res. 57:1993;209-216.
10. Briejer M.R., Akkermans L.M.A., Meulemans A.L., Lefebvre R.A., Schuurkes J.A.J. Naunyn-Schmiedeberg's Arch. Pharmacol. 351:1995;126-135.
11. Solano R.M., Carmena M.J., Carrero I., Cavallaro S., Roman F., Hueso C., Travali S., Lopez-Fraile N., Guijarro L.G., Prieto J.C. Endocrinology. 137:1996;2815-2822.
12. Kawakami F., Okamura H., Inatomi T., Tamada Y., Nakajima T. and Ibata Y. (1994) 174, 81-84.
13. Carmena M.J., Prieto J.C. Biochim. Biophys. Acta. 763:1983;414-418.
14. Bradford M. Anal. Biochem. 72:1976;248-254.
15. Murthy K.S., Makhlouf G.M. J. Biol. Chem. 269:1994;15977-15980.
16. De Vivo M., Maayani S. J. Pharmacol. Exp. Ther. 238:1986;248-253.
17. Seamon K.B., Wetzel B. Adv. Cyclic Nucleotide Protein Phosphorylation Res. 17:1984;91-99.
18. Martin G.R., Humphrey P.P.A. Neuropharmacology. 33:1994;261-273.
19. Harrington M.A., Shaw K., Zhong P., Ciaranello R.D. J. Pharmacol. Exp. Ther. 268:1994;1098-1106.
20. Grider J.R., Murthy K.S., Jin J.G., Makhlouf G.M. Am J. Physiol. 262:1992;6774-6778.